Company / Interest Expense
Altimmune, Inc. Interest Expense History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$8.0K
FY2023
5-year range
$5.0K / $9.4K
FY2019-FY2023
Trend
+60.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 8 years, ranging from $2,244 in FY2020 to $6M in FY2011.
Based on SEC 10-K filings.
$8,000 in FY2023 with a 5-year CAGR of -45.2%.
Improved from $9,421 to $8,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +52.8%
- 5-Year CAGR
- -45.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -45.2%, indicating a declining trend.
- In FY2023, interest expense increased 60.0% year-over-year.
- Peak interest expense was recorded in FY2011.
- Lowest interest expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $8.0K | +60.0% |
| FY2022 | $5.0K | -46.9% |
| FY2021 | $9.4K | +319.8% |
| FY2020 | $2.2K | -99.2% |
| FY2019 | $297.1K | +83.2% |
| FY2018 | $162.1K | +321.2% |
| FY2017 | $38.5K | -99.4% |
| FY2011 | $5.9M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026